https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/aurobindo-pharma-limited-577033-02092023
Aurobindo Pharma Limited - 577033 - 02/09/2023 | FDA
CGMP/Active Pharmaceutical Ingredient (API)/Adulterated
aurobindo pharma limited02 092023fda